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Alzheimer’s disease is the most 
common cause of dementia. When 
the first symptoms of memory deficit 
take place, neuronal damage has 
already irreversibly happened. 
Thus, better ways to achieve an 
earlier diagnosis will need to be 
devised. The aim of this study was 
to explain the relationship of the 
plasma and cerebrospinal fluid 
biomarker levels to cognition and 
brain tissue pathology. The results 
demonstrated that low levels of CSF 
Aβ42 are associated with a high 
amyloid plaque load of brain biopsies. 
In addition, increased CSF tau and 
p-tau levels are associated with the 
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Figure 1. Typical clinical course of early Alzheimer’s disease according to disease stage. (Based 
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Table 1. Research criteria for diagnosis of Alzheimer’s disease (adapted from Dubois, 2007) 
 
Probable AD: Core criteria A and at least one supportive feature (B, C, D or E) 
 
Core criteria 
A. Presence of an early episodic memory impairment with following features: 
1. Gradual and progressive change in memory function over more than 6 months reported by patient 
or an informant 
2. Objective evidence of significantly impaired episodic memory function on testing (recall deficit that 
does not improve with cueing or recognition testing and after effective encoding) 




B. Presence of medial temporal lobe atrophy 
• Volume loss of HC, EC, amygdala on MRI (qualitative rating or volumetric rating) 
C. Abnormal concentration of CSF biomarker 
• Low Aβ42, high tau or p-tau 
• Other well validated biomarker 
D. Specific pattern on functional neuroimaging with PET 
• Reduced glucose metabolism in bilateral temporoparietal regions 
• PIB PET or other well validated ligand 
E. Proven AD autosomal dominant mutation within the immediate family 
 
Exclusion criteria 
Exclusion of other causes by history and clinical features 
 
Definite AD 
• Both clinical AND histopathological (using brain biopsy or autopsy) evidence of AD by NIA-Reagan 
criteria OR 
• Both clinical AND genetic (mutation on chromosome 1, 14 or 21) evidence of AD. 
 
AD = Alzheimer’s disease, HC = hippocampus, EC = entorhinal cortex, MRI = magnetic 
resonance imaging, CSF = cerebrospinal fluid, PET = positron emission tomography, PIB = 
Pittsburgh compound B. 
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Table 2. Studies on longitudinal changes of the CSF biomarkers. 
 
Author Year N AD MCI CH OCD FUT AB42 Tau P-Tau 
           
Blomberg et al. 1996 18 18    14  -   - 
Isoe et al. 1996 9 9    31  -   - 
Kanai et al. 1998 32 32    19    - 
Kanai et al. 1999 33 33    20  -   - 
Andreasen et al. 1998 44 19   21 VaD 12  -   - 
Andreasen et al. 1999 31 16  15   6-27    - 
Andreasen et al. 1999 53 53    10   -  - 
Sunderland et al. 1999 29 29    24  -   - 
Tapiola et al. 2000 17 17    36    - 
Wahlund et al. 2003 47 24 23   16    
Mollenhauer et al. 2005 40 19   21 1,5    
Höglund et al. 2005 19 19    12    
De Leon et al. 2006 16  7 9  21   -   
Bouwman et al. 2007 105 50 38 17  21    
Blennow et al. 2007 53 53    6    
Zetterberg et al. 2007 100  83 17  24    
Andersson et al. 2008 39  25 14  34    
Brys et al. 2009 76  55 21  24    
Buchave et al. 2009 89 45  34  24    - 
Stomrud et al. 2010 37   37  46    
Kester et al. 2011 130 68 62 24  24    
Lo et al. (ADNI) 2011 106 16 54 36  36    

AD = Alzheimer’s disease dementia, MCI = mild cognitive impairment, CH = cognitively healthy, 
OCD = other cognitive disorder, VaD = vascular dementia, FUT = follow-up time (months), 
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Figure 2. Dynamic biomarkers of the Alzheimer's disease pathological cascade (Based on Jack et al. 2010). 
Brain Aβ is identified by CSF Aβ42 or PIB-PET. Tau-mediated neuronal injury and dysfunction is identified 
by CSF tau and p-tau. Brain structure is measured by structural MRI. Aβ = amyloid beta, MCI = mild 
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4.2 LUMBAR PUNCTURE 
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4.3 CSF HANDLING AND STORAGE 
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4.4 ELISA FOR MEASURING AMYLOID BETA AND TAU 
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Table 3. Baseline demographic information of the subjects. 
 









n 806 269  70  
Age 68 (60 – 76) 
70 
(60 - 77) p > 0.1 
71 
(61 - 77) p > 0.1 
Men / 
Women 
321 / 485 
47 % / 53 % 
121 / 148 
45 % / 55 % p > 0.1 
25 / 45 
36 % / 64 % p > 0.1 
APOE ε4 -
/+ 
414 / 207* 
67 % / 33 %  
169 / 99† 
63 % / 37 % p > 0.1 
37 / 33 
53 % / 47 % p > 0.05 
MMSE 26 (7 - 30) 
27 
(13 - 30)  
26 
(17 - 30)  
CDR = 0 731 217  59  
CDR = 0.5 70 51  11  
CDR‡ = 1 3 1  0  
The data is given as median values (range) or as number of subjects with the percentage of all 
subjects in the group. 
*APOE data missing from 185 subjects. 
†APOE data missing from one subject. 
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Figure 3. Formation of the study population. 
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Figure 4. Correlations between the Aβ measurements in 2002-2003 and 2006-2007. The outliers 
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Table 4. Cognition and changes of Aβ between baseline and follow-ups in subjects. 
 
The data are given as medians (interquartile range), unit pg/ml when applicable. 
The values of p reflect the significance against the cognitively stable subgroup. 
*p < 0.05 against "stable or improved". 
 
†Aβ data of one subject is from a plasma sample of 4 years of follow-up. 
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Baseline Cognitively healthy  Cognitively impaired  
n  59 11 
Aβ40 195 (88) 201 (60) 
Aβ42 50 (121) 46 (92) 
Aβ42/Aβ40 0.236 (0.464) 0.291 (0.487) 
  
  
 Cognitively stable or 
improved   Cognitive decline  
Follow-up 3 years 6 years 3 years 6 years 
n 43† 29‡ 27 14 
change of Aβ40 18 (55) 33 (45) 21 (24) 33 (75) 
change of Aβ42   3.7 (29) 12 (54)   0.0 (14)*   -2.4(50)* 
change of  Aβ42/Aβ40 0.0093 
      (0.169) 
0.0166 
     (0.451) 
-0.0027 
       (0.084)* 
-0.0486 





Table 5. Relation of Aβ40 level to medication at baseline 
 Group 1     Aβ40  pg/ml pg/ml 
 n   Users Non-users 
Sex, female 148 -    
Smoking 21 -    
CHD 61 ↑ p=0.035 188 (105 - 360) 176 (0 - 780) 
Diabetes 22 -    
Anticoagulants 16 ↑ p=0.038 198 (144 - 360) 176 (0 - 780) 
NSAIDs 22 -    
ASA 62 ↑ p=0.004 194 (0 - 278) 175 (0 - 780) 
Dipyridamole 12 ↑ p=0.016 208 (156- 278) 176 (0 - 780) 
Antidiabetics* 13 ↑ p=0.003 219 (161 - 426) 179 (0 - 780) 
Lipid lowering 
agents 
24 -    
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Table 6. Demographic information and baseline biomarker concentrations. 
 
 All CH OCD MCI AD p 
N 131 8 10 57 56  
Men/Women, No. 55 / 76  2 / 6  5 / 5  25 / 32 23 / 33 n.s. 
Age, Years † 70 (7) 70 (4) 66 (6) 71 (6) 70 (7) n.s. 
APOE ε4 heterozygote 
(homozygote), No. * 43 (24) 3 (0) 5 (0) 14 (5) 21 (19) 0,005 
MMSE score * 23 (6) 28 (3) 22 (7) 26 (4) 20 (5) <0.001 
Time between CSF 
collection, Months 36 (12) 35 (13) 30 (27) 35 (23) 37 (0,9) 0.002 
Follow-up time of 
cognition, Months 37 (18)  34 (14) 35 (15) 48 (25) 37 (13) n.s. 
CSF Aβ42, pg/ml 439 (296) 560 (274) 507 (334) 578 (377) 379 (144) <0.001 
CSF total tau, pg/ml 373 (342) 306 (175) 214 (225) 283 (263) 480 (475) <0.001 
CSF p-tau-181, pg/ml 72 (48) 58 (37) 41 (35) 59 (31) 90 (53) <0.001 
CSF Aβ42/ptau ratio 6.10 (9.59) 8.80 (8.41) 14.0 (7.10) 10.67 (10.15) 3.96 (2.40) <0.001 
CSF Aβ42/tau ratio 1.13 (2.12) 1.76 (1.54) 3.13 (2.40) 2.10 (2.70) 0.663 (0.647) <0.001 
 
CH = cognitively healthy, OCD = other cognitive disorder. 
Significances are determined using Kruskall-Wallis test. Chi-square test was used for APOE and 
gender. 
The results are presented as median (IQ range). Age is presented as mean (SD). 
†Anova was used due to normal distribution of the variable. 
* Missing one AD and four OCD subjects. 
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Table 7. The effect of APOE genotype and carrier status on biomarker levels at the baseline. 
 
APOE All subjects 
genotype n AB42 Tau P-Tau 
     
4:4 24 360 (105) 608 (550) 112 (69) 
3:4 42 419 (155) 452 (230) 76 (34) 
2:4 1 409 684 116 
3:3 49 546 (379) 253 (249) 54 (37) 
2:3 5 729 (224) 252 (374) 59 (59) 
     
p-value  < 0.001 < 0.001 < 0.001 
     
ε4 + 67 391 (147) 480 (376) 77 (52) 
ε4 - 54 613 (355) 252 (232) 54 (37) 
     
p-value  < 0.001 < 0.001 < 0.001 
     
APOE MCI 
genotype n AB42 Tau P-Tau 
     
4:4 5 358 (425) 512 (445) 69 (44) 
3:4 14 474 (240) 390 (240) 73 (19) 
2:4  -  -  -  - 
3:3 25 677 (418) 229 (142) 51 (23) 
2:3 4 703 (243) 241 (543) 73 (69) 
     
p-value  0.098 0.055 0.012 
     
ε4 + 19 464 (277) 393 (250) 72 (18) 
ε4 - 29 677 (370) 230 (125) 54 (27) 
     
p-value  0.017 0.002 0.009 
     
APOE AD 
genotype n AB42 Tau P-Tau 
     
4:4 19 362(103) 721 (651) 119 (67) 
3:4 20 364 (147) 481 (387) 88 (43) 
2:4 1 409 684 116 
3:3 15 432 (200) 429 (195) 80 (48) 
2:3  -  -  -  - 
     
p-value  0.198 0.103 0.103 
     
ε4 + 40 367 (118) 542 (466) 102 (65) 
ε4 - 15 432 (200) 429 (195) 80 (48) 
     
p-value  0.038 0.025 0.049 

The effect of APOE genotype and carrier status on biomarker levels at the baseline. 
The values are given as median (IQ-range), unit pg/ml. 
The significance was tested by the Kruskall-Wallis (genotypes) and Mann-Whitney tests (carrier 
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Figure 5. Baseline biomarker ratios subdivided into MMSE changing rate quintiles. 
1. quintile = fastest decrease; 5. quintile = slowest decrease 
A) N=131, p < 0.001 (Aβ42/ptau) and p < 0.001 (Aβ42/tau). Kruskall-Wallis test. 
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(Table 8) The values are given as median (IQ range). The biomarker concentration unit is 
pg/ml. The group difference significance is obtained with Kruskall-Wallis test. N.s. = not 
significant. Within group significance between baseline and follow-up: ** < 0.02 level;   
*** < 0.01 level;  † < 0.001 level. Wilcoxon signed rank test. The definite AD group: autopsy 
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Figure 6. Correlations between p-tau-181 changing rate and MMSE score changing rate.  
Correlations without the one lowest outlier: 
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Figure 8. Semi-quantification of Aβ deposits from brain biopsy tissue. 
a) Color image before analysis. Aβ deposits are shown in brown colored immunostain. This 
image has been flat field corrected for uneven illumination.  
b) Threshold image showing Aβ deposits (black) that were selected by software for 
quantification. A single optimal threshold value irrespective of size, shape and intensity 
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Table 10. Demographic characteristics of the patients 
 
  All patients (n = 182) 
AD dementia present 
(n = 51) 
AD dementia 
 not present (n = 130) 
Age, years 72.7 ± 8.8 75.4 ± 7.6 71.7 ± 9.0 
Females, n (%) 90 (46.6) 24 (47.1) 65 (50.0) 
Follow-up time, y 2.01 (1.75) 1.73 (2.11) 2.12 (1.55) 
Immunoreactivity  
in biopsy       
Aβ- Hτ- 85 10 75* 
Aβ+ Hτ- 58 18 40 
Aβ+ Hτ+ 33 22 10* 
Aβ- Hτ+ 6 1 5 
APOE genotype       
ε2/ε3 10 1 9 
ε2/ε4 1 1 0 
ε3/ε3 97 17 79† 
ε3/ε4 38 19 19† 
ε4/ε4 6 4 2 
ε4 carriers, n (%) 45 (23) 24 (47) 21 (16)* 

Data are presented as mean ±SD and median (IQ range) unless indicated otherwise. 
APOE ε4 status was missing for 30 patients. AD diagnosis was missing for one patient. 
*p < 0.001 
†p < 0.01 
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Figure 9. Correlation of ventricular and lumbar CSF Aβ42 (n = 55) 
Pearson correlation coefficient was used. CSF = cerebrospinal fluid, Aβ42 = amyloid beta 1-42. 
Patients with both ventricular and lumbar CSF (n = 55) are included. 
  
  
Table 11. AD biomarker levels in ventricular and lumbar CSF 
 
 Ventricular CSF (n = 55) Lumbar CSF (n = 55) 
Aβ42 497 (226) 584 (179) 
Total tau 1370 (2231) 268 (223) 
P-tau-181 80.3 (90.6) 40.5 (15.5) 
 
Data are presented as mean (SD). The unit is pg/ml. 
Both ventricular and lumbar CSF samples were available for 55 patients. 
p < 0.001 for all biomarkers; ventricular vs. lumbar CSF. 
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Figure 10. Correlation of ventricular and lumbar CSF Aβ42 with cortical brain biopsy Aβ area. All 
patients and AD subgroups. Pearson correlation coefficient was used. 
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Blood and Cerebrospinal 
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Toni Seppälä
Blood and Cerebrospinal Fluid 
Biomarkers of Alzheimer’s Disease
Application in the Evaluation of Progression and 
Differential Diagnosis
Alzheimer’s disease is the most 
common cause of dementia. When 
the first symptoms of memory deficit 
take place, neuronal damage has 
already irreversibly happened. 
Thus, better ways to achieve an 
earlier diagnosis will need to be 
devised. The aim of this study was 
to explain the relationship of the 
plasma and cerebrospinal fluid 
biomarker levels to cognition and 
brain tissue pathology. The results 
demonstrated that low levels of CSF 
Aβ42 are associated with a high 
amyloid plaque load of brain biopsies. 
In addition, increased CSF tau and 
p-tau levels are associated with the 
presence of tau in the cortical biopsy.
